theranostics

You have access
Theranostics in Perspective: White Paper
Marcel P.M. Stokkel, Martin Gotthardt, Ken Herrmann and Gopinath Gnanasegaran

Journal of Nuclear Medicine May 15, 2025, jnumed.125.269776; DOI: https://doi.org/10.2967/jnumed.125.269776
You have access
Dansylated Amino Acid–Modified Long-Acting PSMA Derivatives ⁶⁸Ga/¹⁷⁷Lu-LNC1011 as Prostate Cancer Theranostics
Hongzhang Yang, Jiarou Wang, Xuejun Wen, Huifeng Guo, Vivianne Jakobsson, Tianzhi Zhao, Fantian Zeng, Huaxiang Shen, Heng Zhang, Xiaomin Liu, Yatong Qin, Xinyi Li, Hehe Xiong, Zijian Zhou, Jingjing Zhang and Xiaoyuan Chen

Journal of Nuclear Medicine May 1, 2025, 66 (5) 739-747; DOI: https://doi.org/10.2967/jnumed.124.268959
You have access
A Phase I/II Study of [¹⁷⁷Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol
Sara Harsini, Maryam Soleimani, Don Wilson, Carlos Uribe, Heather Saprunoff, Ingrid Bloise and Francois Benard

Journal of Nuclear Medicine April 30, 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064
You have access
Multicycle Dosimetric Behavior and Dose–Effect Relationships in [¹⁷⁷Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Gunjan Kayal, Molly E. Roseland, Chang Wang, Kellen Fitzpatrick, David Mirando, Krithika Suresh, Ka Kit Wong and Yuni K. Dewaraja

Journal of Nuclear Medicine April 24, 2025, jnumed.124.269389; DOI: https://doi.org/10.2967/jnumed.124.269389
You have access
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy
Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, Ojaswita Lokre, Steve Y. Cho, Scott B. Perlman, Timothy G. Perk and Robert Jeraj

Journal of Nuclear Medicine April 1, 2025, 66 (4) 565-571; DOI: https://doi.org/10.2967/jnumed.124.267809
You have access
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P. Buteau, Grace Kong, Ben Tran, Mohammad B. Haskali, Michael Fahey, Megan Crumbaker, Louise Emmett, Michael S. Hofman and Arun A. Azad

Journal of Nuclear Medicine April 1, 2025, 66 (4) 572-578; DOI: https://doi.org/10.2967/jnumed.124.269252
Open Access
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
Peter J. Gawne, Helen E. Bryant, Steven G. DuBois, Sally L. George, Juliet Gray, Leona Knox, Kyle B. Matchett, Connie Peet, Katherine A. Vallis, Hugh J. Wallace, Simon Wan and Mark N. Gaze

Journal of Nuclear Medicine April 1, 2025, 66 (4) 490-496; DOI: https://doi.org/10.2967/jnumed.124.269121
You have access
[^99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
Yining Sun, Zhixin Hao, Hannan Gao, Guangjie Yang, Bo Pan, Min Zhu, Yakun Wan, Jiyun Shi, Li Huo, Haojun Chen and Fan Wang

Journal of Nuclear Medicine April 1, 2025, 66 (4) 543-551; DOI: https://doi.org/10.2967/jnumed.124.268564
You have access
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy
Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A. Hope and Jeremie Calais

Journal of Nuclear Medicine February 27, 2025, jnumed.124.268818; DOI: https://doi.org/10.2967/jnumed.124.268818
Open Access
Localized In Vivo Prodrug Activation Using Radionuclides
Jeremy M. Quintana, Fangchao Jiang, Mikyung Kang, Victor Valladolid Onecha, Arda Könik, Lei Qin, Victoria E. Rodriguez, Huiyu Hu, Nicholas Borges, Ishaan Khurana, Leou I. Banla, Mariane Le Fur, Peter Caravan, Jan Schuemann, Alejandro Bertolet, Ralph Weissleder, Miles A. Miller and Thomas S.C. Ng

Journal of Nuclear Medicine January 1, 2025, 66 (1) 91-97; DOI: https://doi.org/10.2967/jnumed.124.268559

Main menu

User menu

Search

theranostics

Pages